Narrative reviewcited by the Tayebat archiveabstract only checked A-LEG-01 standard review

NEJM review on favism

Favism and Glucose-6-Phosphate Dehydrogenase Deficiency.

Overview

Luzzatto L, Arese P. N Engl J Med 2018 · PMID 29298156 · DOI 10.1056/nejmra1708111

Authoritative review of favism; no abstract available to us.

Does the study support the specific claim? Partly · Methodological quality: moderate

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Review favism

How was the study done?

Narrative review

How many people, animals or samples were studied?

Not applicable

What was actually found?

Not verified

How large was the observed effect?

Not applicable

What do the results mean in everyday life?

Favism is a recognised condition.

What are the study's limitations?

Content not read.

What does it say about Elawady's specific claim?

Supports favism existence only.

Do the results apply to Germany and Europe?

High

What can explicitly not be concluded from this study?

Cannot justify avoidance for non-deficient people.

Scientific in-depth review

1. Full reference

Authors
Luzzatto L, Arese P
Journal
N Engl J Med
Year
2018
Identifier
PMID 29298156 DOI 10.1056/nejmra1708111
Verification
verified – PubMed E-utilities efetch, 2026-10-25
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

not stated (no abstract)

2. Research question

Mechanisms and clinical features of favism in G6PD deficiency.

3. Study design and population

Study design
Narrative review – Narrative review article (NEJM Review Article)
Population

Not applicable (review)

Country

Not applicable

Period

Not applicable

Sample size

Not applicable

Inclusion and exclusion criteria

Not reported (no abstract)

4. Methods and endpoints

Exposure / intervention

Fava bean ingestion in G6PD deficiency

Comparator

Not applicable

Endpoints

Not applicable

Statistical methods

Not applicable

5. Actual results

Results

No abstract in PubMed; content not read.

Absolute risks

not reported

Authors' conclusion

Not available (no abstract).

6. Strengths

  • Authoritative authors and journal

7. Weaknesses

  • No abstract available; content not verified by us

8. Risk of bias

Orienting tool
none applicable
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
not assessable
Rationale

Narrative review; full text not accessed.

9. Assessment of the statistical interpretation

Not applicable.

10. Relevance to the specific claim

Supports the existence of favism (C-LEG-03).

11. Independent contrary findings

None on the core point.

12. Transferability to Germany and Europe

High.

13. Overall methodological judgement

Reputable review; supports favism as an entity; content not read.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitymoderate
Risk of biasnot assessable
Precision of resultsnot applicable
Directnessdirect
Reproducibilityreplicated
Consistency with the overall evidenceconsistent
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)not verifiable

14. Open questions

Full text not accessed.

15. Linked fact checks

Use by the Tayebat archive

Note: according to the archive, the studies were compiled by the archive operators. Whether Dr. Elawady himself cited this study is not established.

What the archive says about the study

Listed in the bibliography as background on favism.

A. What was actually studied?

Review of favism.

B. What did the authors find?

Not verifiable from PubMed record (no abstract).

C. What conclusions do the authors themselves draw?

Not verifiable.

D. What does the archive derive from it?

Used as general support for favism risk.

E. Is this derivation scientifically justified?

Justified only for favism in G6PD-deficient people, not for universal legume avoidance.

Adequacy of the interpretation (by the archive)
not verifiable